Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThruvision Grp Regulatory News (THRU)

Share Price Information for Thruvision Grp (THRU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.50
Bid: 15.00
Ask: 16.00
Change: 0.00 (0.00%)
Spread: 1.00 (6.667%)
Open: 15.50
High: 15.50
Low: 15.50
Prev. Close: 15.50
THRU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

26 Oct 2022 11:50

RNS Number : 2089E
Thruvision Group PLC
26 October 2022
 

RNS

26 October 2022

Thruvision Group plc

 

("Thruvision")

 

Result of Annual General Meeting

 

 

Thruvision (AIM:THRU), the leading provider of "safe distance" people-screening technology to the international security market, announces that following the Annual General Meeting ("AGM") held earlier today at Investec, 30 Gresham Street, London, EC2V 7QP, all resolutions were duly passed by the requisite majority. The number of proxies received in respect of each resolution were as follows:

 

Resolution

Total votes for

%

Total votes against

%

Total votes cast

 

Votes withheld

1.

Receipt of directors and auditors report

115,297,357

100.00

0

0.00

115,297,357

4,297

2.

Approval of remuneration report

115,278,881

99.98

17,546

0.02

115,296,357

5,297

3.

Re-election of Tom Black

114,011,970

98.88

1,286,806

1.12

115,298,776

2,878

4.

Re-election of Colin Evans

115,294,106

100.00

4,670

0.00

115,298,776

2,878

5.

Re-election of Richard Amos

115,294,106

100.00

4,670

0.00

115,298,776

2,878

6.

Election of Katrina Nurse

115,294,106

100.00

4,670

0.00

115,298,776

2,878

7.

Election of Victoria Balchin

115,294,106

100.00

4,670

0.00

115,298,776

2,878

8.

Appointment of Auditors

115,291,230

99.99

7,546

0.01

115,298,776

2,878

9.

Authority for Directors to set Auditors remuneration

115,294,106

100.00

4,670

0.00

115,298,776

2,878

10.

Authority for Directors to allot equity securities

 

115,294,106

100.00

4,670

0.00

115,298,776

2,878

11.

Authority for Directors to allot equity securities for cash on a non-premptive basis

115,294,106

100.00

4,670

0.00

115,298,776

2,878

12.

Authority for Directors to allot equity securities for cash in respect of an acquisition or other capital project.

115,294,106

100.00

4,670

0.00

115,298,776

2,878

13. 

Authority for the Company to make market purchases of its own Ordinary Shares

115,293,106

100.00

5,670

0.00

115,298,776

2,878

Notes

1. Any proxy appointments which gave discretion to the Chairman have been included in the 'Total votes for' total.

2. A 'Vote Withheld' is not a valid vote in law and was not counted in the calculation of the proportion of the votes 'for' or 'Against' a resolution. 

 

 

 

 

For further information please contact:

 

Thruvision Group plc

+44 (0)1235 425400

Tom Black, Executive Chairman

Colin Evans, Chief Executive

Investec Investment Banking (NOMAD & Broker)

+44 (0)20 7597 5970

Patrick Robb / James Rudd / Sebastian Lawrence

FTI Consulting LLP

+44 (0)20 3727 1000

Matt Dixon / Tom Blundell

 

 

 

About Thruvision

Addressing the urgent need for "safe distance" people security screening in the COVID era, Thruvision is uniquely capable of detecting metallic and non-metallic items including weapons, explosives and contraband items that are hidden under clothing, at distances between 3 and 10m. Using patented passive terahertz technology, Thruvision completely removes the need for physical "pat-downs" and has been vetted and approved by the US Transportation Security Administration for surface transportation. Operationally deployed in 20 countries around the world, Thruvision is used for aviation security, retail supply chain loss prevention, customs and border control, and public area security. The company has offices near Oxford and Washington DC.

www.thruvision.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGFEUFSMEESELS
Date   Source Headline
21st Feb 20222:07 pmRNSExercise of Sharesave Share Options
25th Jan 20224:06 pmRNSSharesave option grant to Executive Director
24th Dec 20217:00 amRNSDirector Share Dealing
22nd Dec 202112:42 pmRNSHolding(s) in Company
2nd Dec 20216:00 pmRNSDirector Share Dealing
2nd Dec 20212:00 pmRNSInvestor Presentation
1st Dec 202111:36 amRNSDirector Share Dealing
30th Nov 20215:39 pmRNSAward of Share Options to Executive Directors
30th Nov 20211:50 pmRNSDirector Share Dealing
22nd Nov 20217:00 amRNSInterim Results
11th Nov 20217:00 amRNSNotice of Interim Results
27th Oct 20218:52 amRNSBlocklisting application
7th Oct 20217:00 amRNSTrading Update
4th Oct 20219:10 amRNSBlocklisting update
28th Sep 202110:31 amRNSResult of Annual General Meeting
2nd Sep 20217:00 amRNSDirector/PDMR Shareholding
12th Aug 20217:00 amRNSDirector Share Dealing
27th Jul 20211:00 pmRNSDirector/PDMR Shareholding
16th Jul 20213:27 pmRNSReplacement: Holding(s) in Company
15th Jul 20214:43 pmRNSHolding(s) in Company
12th Jul 20217:00 amRNSResults for the Year ended 31 March 2021
9th Jul 20212:34 pmRNSReplacement: Investor Presentation
9th Jul 202111:00 amRNSInvestor Presentation
5th Jul 202112:00 pmRNSNotice of Results
27th May 20211:24 pmRNSDirector Share Dealing
1st Apr 20217:00 amRNSPre-Close Statement
31st Mar 20213:00 pmRNSBlocklisting update
11th Mar 20215:53 pmRNSHolding(s) in Company
10th Mar 20213:33 pmRNSHolding(s) in Company
24th Feb 20217:00 amRNSAppointment of Non-Executive Director
1st Dec 20207:00 amRNSThruvision Investor Presentation
23rd Nov 20207:00 amRNSInterim Results
10th Nov 20207:00 amRNSNotice of Interim Results
9th Oct 202010:18 amRNSHolding(s) in Company
7th Oct 20207:00 amRNSPre-close Trading Update
22nd Sep 202010:31 amRNSResult of Annual General Meeting
18th Sep 20207:00 amRNSContract award announcement
26th Jun 202010:32 amRNSHolding(s) in Company
23rd Jun 20205:21 pmRNSHolding(s) in Company
22nd Jun 20204:24 pmRNSHolding(s) in Company
17th Jun 202011:05 amRNSSecond Price Monitoring Extn
17th Jun 202011:01 amRNSPrice Monitoring Extension
16th Jun 20207:00 amRNSAward of Share Options to Executive Directors
8th Jun 20207:00 amRNSResults for the Year ended 31 March 2020
3rd Jun 20207:22 amRNSNotice of Annual Results
3rd Jun 20207:00 amRNSNotice of Annual Results
2nd Apr 20207:40 amRNSTrading Statement
25th Nov 20197:00 amRNSInterim Results
19th Nov 20197:00 amRNSNotice of Interim Results
13th Nov 20193:28 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.